We are live on ! Find out more
CA

Capitolis Advisors Portfolio holdings

AUM $1.41B
1-Year Est. Return 17.33%
This Fund
S&P 500
This Quarter Est. Return
+0.68%
1 Year Est. Return
-17.33%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$11B
AUM Growth
+$2.49B
Cap. Flow
+$2.51B
Cap. Flow %
22.79%
Top 10 Hldgs %
32.26%
Holding
468
New
64
Increased
98
Reduced
125
Closed
64

Top Buys

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$379M
2
AAPL icon
Apple
AAPL
+$351M
3
AMZN icon
Amazon
AMZN
+$325M
4
MSFT icon
Microsoft
MSFT
+$212M
5
AVGO icon
Broadcom
AVGO
+$204M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$413M
2
WFC icon
Wells Fargo
WFC
+$137M
3
PANW icon
Palo Alto Networks
PANW
+$71M
4
GSK icon
GSK
GSK
+$60.7M
5
WMT icon
Walmart Inc
WMT
+$54.4M

Sector Composition

Rank Sector Weight
1 Technology 29.03%
2 Financials 17.42%
3 Consumer Discretionary 11.29%
4 Real Estate 10.27%
5 Healthcare 9.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BWXT icon
301
BWX Technologies
BWXT
$16.2B
$1.79M 0.02%
31,636
RITM icon
302
Rithm Capital
RITM
$5.01B
$1.67M 0.02%
+146,897
New +$1.51M
SYY icon
303
Sysco
SYY
$39.1B
$1.63M 0.01%
20,049
-9,579
-32% -$731K
MAS icon
304
Masco
MAS
$15.6B
$1.59M 0.01%
26,469
-9,039
-25% -$536K
CPRT icon
305
Copart
CPRT
$25.2B
$1.59M 0.01%
43,068
-80,920
-65% -$2.89M
RMD icon
306
ResMed
RMD
$27.8B
$1.58M 0.01%
6,163
-2,279
-27% -$623K
NSC icon
307
Norfolk Southern
NSC
$78.3B
$1.57M 0.01%
5,710
-2,492
-30% -$639K
APTV icon
308
Aptiv
APTV
$11.9B
$1.57M 0.01%
9,332
IVZ icon
309
Invesco
IVZ
$13.2B
$1.56M 0.01%
63,273
-13,013
-17% -$325K
LH icon
310
Labcorp
LH
$23.9B
$1.56M 0.01%
6,606
CDW icon
311
CDW
CDW
$16.6B
$1.55M 0.01%
8,312
ROST icon
312
Ross Stores
ROST
$74.5B
$1.54M 0.01%
14,033
-6,704
-32% -$803K
ADM icon
313
Archer Daniels Midland
ADM
$41.6B
$1.52M 0.01%
23,902
-10,466
-30% -$628K
CTAS icon
314
Cintas
CTAS
$81.3B
$1.44M 0.01%
13,712
-6,552
-32% -$641K
DLTR icon
315
Dollar Tree
DLTR
$22.6B
$1.4M 0.01%
13,827
ACN icon
316
Accenture
ACN
$84.9B
$1.39M 0.01%
4,036
-46,035
-92% -$15M
MDLZ icon
317
Mondelez International
MDLZ
$77.1B
$1.34M 0.01%
22,460
-26,904
-55% -$1.67M
OTIS icon
318
Otis Worldwide
OTIS
$27.2B
$1.34M 0.01%
16,051
-7,668
-32% -$674K
CPAY icon
319
Corpay
CPAY
$23.8B
$1.32M 0.01%
4,899
NUE icon
320
Nucor
NUE
$54.9B
$1.32M 0.01%
12,843
-4,747
-27% -$505K
PPG icon
321
PPG Industries
PPG
$25.4B
$1.27M 0.01%
8,084
-33,310
-80% -$5.34M
SNPS icon
322
Synopsys
SNPS
$71.5B
$1.25M 0.01%
4,086
MNST icon
323
Monster Beverage
MNST
$91.5B
$1.24M 0.01%
29,110
-13,908
-32% -$657K
JHG
324
DELISTED
Janus Henderson
JHG
$1.22M 0.01%
+27,243
New +$1.13M
MKL icon
325
Markel Group
MKL
$24.5B
$1.17M 0.01%
+900
New +$1.11M

Similar funds

Capitolis Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Capitolis Advisors held 468 positions worth $11B, up 29% from $8.51B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Capitolis Advisors deployed $2.51B of net new capital in Q3 2021, opening 64 new positions and adding to 98 existing holdings. Its largest new stake was iShares MSCI Emerging Markets ETF: 2,060,000 shares worth $107M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Palo Alto Networks, an estimated $71M trimmed.

  • Capitolis Advisors's largest Q3 2021 buy was iShares MSCI Emerging Markets ETF: 2,060,000 shares worth $107M.
  • Capitolis Advisors added most to Intuitive Surgical in Q3 2021, an estimated $379M increase.
  • Capitolis Advisors's biggest Q3 2021 reduction was Palo Alto Networks, cutting an estimated $71M.
  • Capitolis Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $413M.
  • Capitolis Advisors's ten largest holdings make up 32% of its $11B portfolio in Q3 2021.
  • Capitolis Advisors opened 64 new positions and closed 64 in Q3 2021.
  • Capitolis Advisors's portfolio value rose 29% quarter-over-quarter to $11B.

Based on Capitolis Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.